Full-Time
Business Development Manager
Cdmo, Therapeutics/Life Science
Posted on 6/11/2025
LGC Group
1,001-5,000 employees
Provides scientific tools for life sciences
No salary listed
Senior, Expert
Franklin, MA, USA
Preference for candidates to be based in MA. Willing to travel up to 50%, including overnight trips, as required.
- Bachelor’s degree in a relevant field; additional business qualifications are a plus
- Proven experience in winning new business in the pharma, biotech, or CDMO sectors
- Strong understanding of drug development and regulatory landscapes
- Expertise in external communication with customers, prospects, and industry partners
- Self-motivated, goal-driven and comfortable navigating complex sales cycles.
- Proactively identify and pursue new business opportunities in the nucleic acid therapeutics field
- Collaborate with Business Intelligence to uncover high-potential leads
- Promote Axolabs as a leading, multi-site CRO/CDMO to enhance market visibility
- Build and nurture strong, lasting relationships with prospects and customers
- Drive business growth through a structured sales process and strategic negotiations
- Preference for the chosen candidate to be based in MA
- Willing to travel up to 50%, including overnight trips, as required
LGC Group provides scientific tools and solutions that support advancements in healthcare and pharmaceuticals. Their products include oligo components, probes, primers, and recombinant viral materials, which are essential for detecting diseases and developing vaccines and therapies for various illnesses, including cancer and infectious diseases. LGC's focus on life sciences, particularly in areas like mass spectrometry and immunoassay, sets them apart from competitors. They also offer proficiency testing schemes to ensure food safety. The company's goal is to improve healthcare outcomes and contribute to a safer world through high-quality scientific innovations.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
1841
Simplify's Take
What believers are saying
- Increased demand for nucleic acid-based diagnostics boosts LGC's growth potential.
- AI integration in diagnostics enhances LGC's proficiency testing services.
- LGC's acquisitions strengthen its position in serology and molecular quality controls.
What critics are saying
- Integration challenges from DiaMex and Virusys acquisitions may disrupt operations.
- New CEO Joydeep Goswami might cause strategic shifts affecting business operations.
- Expansion into smart home projects could divert focus from core life sciences.
What makes LGC Group unique
- LGC Group offers high-quality scientific tools for healthcare and pharmaceuticals.
- The company specializes in nucleic acid chemistry and recombinant viral materials.
- LGC's proficiency testing schemes ensure food safety and critical area monitoring.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Hybrid Work Options
Remote Work Options
Company News
Graham B Jackson Pty Ltd (GBJPL), an Australian leader in reference materials, partners with the globally renowned LGC Group to supply high-quality CRMs to laboratories across the country.
For example, LGC Group introduced a proficiency testing (PT) service in April 2020 that uses nucleic acid amplification testing to identify SARS-CoV-2 (COVID-19).
UK-based LGC, an international life sciences measurement and tools company, has appointed Joydeep Goswami as president and CEO, succeeding Euan O'Sullivan, who decided to step down from his role in early 2024 after fourteen years of service.
London, UK – 4 December 2024 – LGC today announces an addition to its growing global clinical diagnostics and genomics portfolio, following the acquisition of DiaMex, a manufacturer of third-party serology and molecular quality controls used in clinical laboratories and blood banks across the world.
LGC acquires DiaMex to drive innovation and choice for core laboratory customers: acquisition complements LGC's serology and molecular quality control portfolio and enhances choice of products from a single supplier.